Publications

2012:

Effects of Activin and TGFβ on p21 in Colon Cancer.

Bauer J, Sporn JC, Cabral J, Gomez J, Jung B.

PLoS One. 2012;7(6):e39381. Epub 2012 Jun 26.

Differential Regulation and Predictive Potential of MacroH2A1 Isoforms in Colon Cancer.

Sporn JC, Jung B.

Am J Pathol. 2012 Jun;180(6):2516-26. Epub 2012 Apr 27.

Microsatellite instability, EMAST, and morphology associations with T cell infiltration in colorectal neoplasia.

Lee SY, Miyai K, Han HS, Hwang DY, Seong MK, Chung H, Jung BH, Devaraj B, McGuire KL, Carethers JM.

Dig Dis Sci. 2012 Jan;57(1):72-8. Epub 2011 Jul 20.

2011:

BARD1 expression predicts outcome in colon cancer.

Sporn JC, Hothorn T, Jung B.

Clin Cancer Res. 2011 Aug 15;17(16):5451-62. doi: 10.1158/1078-0432.CCR-11-0263. Epub 2011 Jun 21.

Expression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.

Garcia-Marcos M, Jung BH, Ear J, Cabrera B, Carethers JM, Ghosh P.

FASEB J. 2011 Feb;25(2):590-9. Epub 2010 Oct 25.

2010:

Microsatellite alterations at selected tetranucleotide repeats are associated with morphologies of colorectal neoplasias.

Lee SY, Chung H, Devaraj B, Iwaizumi M, Han HS, Hwang DY, Seong MK, Jung BH, Carethers JM.

Gastroenterology. 2010 Nov;139(5):1519-25. Epub 2010 Aug 11.

A G{alpha}i-GIV molecular complex binds epidermal growth factor receptor and determines whether cells migrate or proliferate.

Ghosh P, Beas AO, Bornheimer SJ, Garcia-Marcos M, Forry EP, Johannson C, Ear J, Jung BH, Cabrera B, Carethers JM, Farquhar MG.

Mol Biol Cell. 2010 Jul 1;21(13):2338-54. Epub 2010 May 12.

2009:

Activin signaling in microsatellite stable colon cancers is disrupted by a combination of genetic and epigenetic mechanisms.

Jung B, Gomez J, Chau E, Cabral J, Lee JK, Anselm A, Slowik P, Ream-Robinson D, Messer K, Sporn J, Shin SK, Boland CR, Goel A, Carethers JM.

PLoS One. 2009 Dec 14;4(12):e8308.

Upregulation of activin signaling in experimental colitis.

Zhang YQ, Resta S, Jung B, Barrett KE, Sarvetnick N.

Am J Physiol Gastrointest Liver Physiol. 2009 Oct;297(4):G768-80. Epub 2009 Jul 30.

2007:

Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.

Shin SK, Nagasaka T, Jung BH, Matsubara N, Kim WH, Carethers JM, Boland CR, Goel A.

Gastroenterology. 2007 Dec;133(6):1849-57. Epub 2007 Sep 5.

BMP-induced growth suppression in colon cancer cells is mediated by p21WAF1 stabilization and modulated by RAS/ERK.

Beck SE, Jung BH, Del Rosario E, Gomez J, Carethers JM.

Cell Signal. 2007 Jul;19(7):1465-72. Epub 2007 Jan 24.

Activin type 2 receptor restoration in MSI-H colon cancer suppresses growth and enhances migration with activin.

Jung BH, Beck SE, Cabral J, Chau E, Cabrera BL, Fiorino A, Smith EJ, Bocanegra M, Carethers JM.

Gastroenterology. 2007 Feb;132(2):633-44. Epub 2006 Nov 16.

Bone morphogenetic protein signaling and growth suppression in colon cancer.

Beck SE, Jung BH, Fiorino A, Gomez J, Rosario ED, Cabrera BL, Huang SC, Chow JY, Carethers JM.

Am J Physiol Gastrointest Liver Physiol. 2006 Jul;291(1):G135-45.

2006:

Influence of target gene mutations on survival, stage and histology in sporadic microsatellite unstable colon cancers.

Jung B, Smith EJ, Doctolero RT, Gervaz P, Alonso JC, Miyai K, Keku T, Sandler RS, Carethers JM.

Int J Cancer. 2006 May 15;118(10):2509-13.

2004:

Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers.

Jung B, Doctolero RT, Tajima A, Nguyen AK, Keku T, Sandler RS, Carethers JM.

Gastroenterology. 2004 Mar;126(3):654-9.

2003:

Aphthous colitis in a young man with diverticulitis.

Jung B, Carethers JM, Behling C, Garvie JJ.

Gastrointest Endosc. 2003 Aug;58(2):301-4. No abstract available.